in general , although patients with parathyroid carcinomas have more profound metabolic abnormalities than do patients with primary hyperparathyroidism , the metabolic manifestations in patients with parathyroid carcinoma are comparable with those in patients with parathyroid adenomas and profound hypercalcemia .
C0221002
primary hyperparathyroidism
C0262587
parathyroid adenomas